Zydus Cadila Enters Vaccines Market by Acquiring Etna Biotech

By Taskin Ahmed

Pharma Deals Review: Vol 2008 Issue 102 (Table of Contents)

Published: 11 Nov-2008

DOI: 10.3833/pdr.v2008.i102.113     ISSN: 1756-7874

Section: Mergers & Acquisitions



Indian Pharmaceutical company, Zydus Cadila, has stepped into the vaccines market with the acquisition of vaccine developer, Etna Biotech, a subsidiary of Crucell NV of The Netherlands...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details